US18978H2013 - Common Stock
CNS PHARMACEUTICALS INC
NASDAQ:CNSP (4/19/2024, 9:33:38 AM)
0.2103
+0.01 (+3.09%)
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. The company is headquartered in Houston, Texas and currently employs 3 full-time employees. The company went IPO on 2019-11-08. The firm's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The firm is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.
CNS PHARMACEUTICALS INC
2100 West Loop S Ste 900
Houston TEXAS 77027
P: 18009469185
CEO: John Climaco
Employees: 3
Website: https://cnspharma.com/
CNS Pharmaceuticals just reported results for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CNS Pharmaceuticals (NASDAQ:CNSP) just reported results for the fourth quarter ...
We're starting off trading on Tuesday with a look into the biggest pre-market stock movers traders need to keep an eye on today!
CNS Pharmaceuticals announces public offering of 13.3 million shares at $0.30 per share, accompanied by Series A and Series B Warrants.
Read about CNS Pharmaceuticals' filing of a prospectus for the sale of 3.81M common stock.
Here you can normally see the latest stock twits on CNSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: